Back to top

Goldman Sachs Remains a Buy on Astellas Pharma (ALPMF)

In a report released today, from Goldman Sachs maintained a Buy rating on Astellas Pharma, with a price target of Yen3,100.00. The word on The Stre...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Astellas Pharma Inc. (ALPMY)